Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
These results indicate that treatment with GABA, DSIP-CBBBP and more effectively reduced wakefulness time, with DSIP-CBBBP showing the most substantial reduction, suggesting its potential as a therapeutic agent for mitigating insomnia
Nature 505, 344352
You may face difficulty concentrating or learning new things
In diseases like asthma and ARDS, dysregulated arginine metabolism characterized by increased ADMA levels and reduced NO production, leads to epithelial dysfunction and increased oxidative stress
US$ 27.24
US$ 28.94
US$ 27.35
